Quick Answer
Biohaven Ltd. reported Earnings Per Share Diluted of $6.86 (loss) per share for the year ending 2025.
- Biohaven Ltd. showed an increase of +26.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Biohaven Ltd.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $1.38 (loss) per share | Q1 2022: $2.46 (loss) per share | Q2 2022: $5.16 (loss) per share | Q3 2022: $1.75 (loss) per share | Q1 2023: $1.03 (loss) per share | Q2 2023: $1.32 (loss) per share | Q3 2023: $1.50 (loss) per share | Q1 2024: $2.20 (loss) per share | Q2 2024: $3.64 (loss) per share | Q3 2024: $1.70 (loss) per share | Q1 2025: $2.17 (loss) per share | Q2 2025: $1.94 (loss) per share | Q3 2025: $1.64 (loss) per share.
- Over the full 6 years of available data (2020 to 2025), Biohaven Ltd.'s Earnings Per Share Diluted has declined by 127.9%.
- Historical annual values: Fiscal year 2025: $6.86 (loss) per share | Fiscal year 2024: $9.28 (loss) per share | Fiscal year 2023: $5.73 (loss) per share | Fiscal year 2022: $12.75 (loss) per share | Fiscal year 2021: $5.43 (loss) per share | Fiscal year 2020: $3.01 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: